Letters
GPs' prescribing behaviour may be affected by drug promotion
BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7053.367a (Published 10 August 1996) Cite this as: BMJ 1996;313:367
- Paramjit S Gill,
- Nick Freemantle,
- Lisa Bero,
- Flora Haaijer-Ruskamp,
- Marjukka Markela,
- Kaveh P Barjesteh
- Senior lecturer Department of Primary Care and Population Sciences, University College London and Royal Free Hospital Schools of Medicine, Whittington Hospital, London N19 5NF
- Research fellow Department of Health Sciences and Clinical Evaluation, University of York, York YO1 5DD
- Assistant professor Institute for Health Policy Studies, Division of Clinical Pharmacy, University of California, San Francisco, CA 94109, USA
- Professor Department of Health Sciences, University of Groningen, 9713 AV Groningen, Netherlands
- Head of research and development Research and Development Centre for Welfare and Health Services and Quality, PO Box 220, 00531 Helsinki, Finland
- Resident pharmacist Group Health Cooperative of Puget Sound, PO Box 20547, Seattle, WA 98102-1547, USA
EDITOR,—David Armstrong and colleagues studied why doctors changed their prescribing behaviour over six months and found that multiple factors were involved.1 We would add several points.
Firstly, it is surprising that the authors mention the role of drug promotion only …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.